Blog
RSS FeedPosted by Michael Wonder on 20 Aug 2020
New agreement means NICE recommends combination treatment for some lymphoma patients
20 August 2020 - Hundreds of people with a form of blood cancer will benefit from a new treatment following the ...
Posted by Michael Wonder on 19 Aug 2020
Keeping pace with pharmaceutical innovation: the importance of the NICE methods review
19 August 2020 - The NICE plays a vitally important role in ensuring patients get timely access to new medicines ...
Posted by Michael Wonder on 18 Aug 2020
NICE appoints two directors to key new positions
18 August 2020 - NICE has announced the appointment of two new directors to key positions in newly formed directorates. ...
Posted by Michael Wonder on 17 Aug 2020
Janssen and others have appealed NICE's decision to reject abiraterone acetate for patients with for high risk hormone-sensitive metastatic prostate cancer
17 August 2020 - The appeal panel will convene on 3 September and 4 September to hear oral representations from the ...
Posted by Michael Wonder on 17 Aug 2020
NICE publishes guidance on Astellas' Xospata
17 August 2020 - The National Institute for Health and Care Excellence has now published final guidance backing NHS use ...
Posted by Michael Wonder on 13 Aug 2020
NICE recommends Adcetris for first-line use for patients with a rare form of non-Hodgkin's lymphoma
12 August 2020 - NICE has published its final guidance on the use of brentuximab vedotin in combination with chemotherapy ...
Posted by Michael Wonder on 12 Aug 2020
What is it going to be, TTO or SG? A direct test of the validity of health state valuation
12 August 2020 - It has been suggested that time trade-off yields more accurate health state valuations, because time trade-off ...
Posted by Michael Wonder on 06 Aug 2020
NICE supports use of new medicine for patients with malignant disease
5 August 2020 - Treosulphan is used as part of conditioning treatment prior to allogeneic haematopoietic stem cell transplantation. ...
Posted by Michael Wonder on 05 Aug 2020
NICE publishes draft guidance on the use of a topical gel by patients with a rare cancer
5 August 2020 - The Department of Health and Social Care has asked NICE to produce guidance on using chlormethine gel ...
Posted by Michael Wonder on 04 Aug 2020
UK increases COVID-19 vaccine manufacturing capacity
4 August 2020 - The UK government has signed a new deal with biotech organisation Wockhardt to increase the manufacturing ...
Posted by Michael Wonder on 31 Jul 2020
NICE recommends Bavencio (avelumab) in combination with axitinib for first-line treatment of adult patients with advanced renal cell carcinoma
31 July 2020 - This is the first combination of an immunotherapy with a targeted antiangiogenic therapy to be recommended ...
Posted by Michael Wonder on 30 Jul 2020
NICE rejects NHS funding for Kyowa Kirin's Poteligeo
30 July 2020 - NICE is not recommending NHS funding for Kyowa Kirin's Poteligeo (mogamulizumab) as a treatment for mycosis ...
Posted by Michael Wonder on 29 Jul 2020
Sanofi and GSK agree with the UK government to supply up to 60 million doses of COVID-19 vaccine
29 July 2020 - Both companies are committed to making their COVID-19 vaccine candidate affordable and available globally. ...
Posted by Michael Wonder on 20 Jul 2020
Developing NICE guidelines
17 July 2020 - NICE has published interim process and methods for guidelines developed in response to health and social ...
Posted by Michael Wonder on 20 Jul 2020
Government signs deals with BioNTech/Pfizer and Valneva for COVID vaccines
20 July 2020 - The Government has signed new deals with BioNTech/Pfizer and Valneva for access to 90 million doses ...